Real life experiences in HCV management in 2018

Mauro Viganò, Massimo Andreoni, Carlo Federico Perno, Antonio Craxì, Alessio Aghemo, Alfredo Alberti, Pietro Andreone, Sergio Babudieri, Stefano Bonora, Maurizia Rossana Brunetto, Raffaele Bruno, Savino Bruno, Vincenza Calvaruso, Nicola Caporaso, Fabio Cartabellotta, Francesca Ceccherini-Silberstein, Valeria Cento, Alessia Ciancio, Piero Colombatto, Nicola CoppolaVito Di Marco, Giovanni Di Perri, Stefano Fagiuoli, Giovanni Battista Gaeta, Antonio Gasbarrini*, Pietro Lampertico, Adriano Pellicelli, Tullio Prestileo, Massimo Puoti, Giovanni Raimondo, Giuliano Rizzardini, Gloria Taliani, Anna Linda Zignego

*Corresponding author

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

n/a
Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalExpert Review of Anti-Infective Therapy
DOIs
Publication statusPublished - 2018

Keywords

  • Antiviral therapy
  • DAAs
  • HCV
  • chronic liver disease
  • direct acting antivirals
  • hepatitis C virus

Fingerprint

Dive into the research topics of 'Real life experiences in HCV management in 2018'. Together they form a unique fingerprint.

Cite this